1832 Asset Management
DGX icon

1832 Asset Management’s Quest Diagnostics DGX Stock Holding History

1832 Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,836
Closed -$1.5M – 689
2025
Q1 		$1.5M Sell
8,836
-3,096
-26% -$509K ﹤0.01% 524
2024
Q4 		$1.8M Buy
11,932
+383
+3% +$59.6K ﹤0.01% 506
2024
Q3 		$1.79M Sell
11,549
-1,903
-14% -$284K ﹤0.01% 545
2024
Q2 		$1.84M Sell
13,452
-968
-7% -$133K ﹤0.01% 510
2024
Q1 		$1.92M Sell
14,420
-114
-0.8% -$14.8K ﹤0.01% 511
2023
Q4 		$2M Buy
14,534
+206
+1% +$27.1K ﹤0.01% 488
2023
Q3 		$1.75M Sell
14,328
-1,424
-9% -$190K ﹤0.01% 506
2023
Q2 		$2.21M Buy
15,752
+56
+0.4% +$7.72K ﹤0.01% 467
2023
Q1 		$2.22M Buy
15,696
+2,516
+19% +$360K ﹤0.01% 493
2022
Q4 		$2.06M Sell
13,180
-2,090
-14% -$300K ﹤0.01% 521
2022
Q3 		$1.87M Sell
15,270
-1,841
-11% -$242K ﹤0.01% 522
2022
Q2 		$2.27M Buy
17,111
+929
+6% +$127K ﹤0.01% 496
2022
Q1 		$2.18M Buy
+16,182
New +$2.26M ﹤0.01% 537
2021
Q4 		– Sell
-213,193
Closed -$31.7M – 755
2021
Q3 		$31.7M Buy
213,193
+4,445
+2% +$650K 0.06% 213
2021
Q2 		$27.7M Buy
208,748
+5,000
+2% +$655K 0.05% 228
2021
Q1 		$26.3M Buy
203,748
+185,048
+990% +$22.8M 0.06% 226
2020
Q4 		$2.22M Hold
18,700
– – 0.01% 441
2020
Q3 		$2.14M Buy
18,700
+14,760
+375% +$1.74M 0.01% 416
2020
Q2 		$380K Hold
3,940
– – ﹤0.01% 493
2020
Q1 		$282K Buy
3,940
+1,029
+35% +$107K ﹤0.01% 540
2019
Q4 		$262K Sell
2,911
-7,383
-72% -$770K ﹤0.01% 504
2019
Q3 		$914K Buy
10,294
+4,182
+68% +$429K ﹤0.01% 433
2019
Q2 		$515K Buy
+6,112
New +$587K ﹤0.01% 498
2019
Q1 		– Sell
-140
Closed -$12K – 639
2018
Q4 		$12K Buy
+140
New +$13.1K ﹤0.01% 550

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

1832 Asset Management's DGX Position: Q2 2025 in Review

1832 Asset Management sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 8,836 shares — an estimated $1.5M sold.

1832 Asset Management first reported a position in DGX in Q4 2018 and held it in 24 quarters. The position peaked at $31.7M in Q3 2021. 991 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • 1832 Asset Management reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • 1832 Asset Management sold 8,836 Quest Diagnostics shares in Q2 2025, an estimated $1.5M.
  • 1832 Asset Management first reported a position in Quest Diagnostics in Q4 2018 and held it in 24 quarters.
  • 1832 Asset Management's Quest Diagnostics position peaked at $31.7M in Q3 2021.
  • 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on 1832 Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.